Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
ARWR
$67.27
Arrowhead Pharma
$1.74
2.66%
ARWR
Earnings Whisper ®
N/A
1st Quarter December 2019
Consensus: ($0.03)
Revenue: $31.00 Mil
Monday
Feb 24
4:00 PM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Monday, November 25, 2019
Arrowhead Pharmaceuticals Reports Fiscal Year 2019 Results
What do you expect when ARWR reports earnings?
Beat
Meet
Miss
Where is ARWR's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$72.25
$70.62
$68.95
$67.32
Support
$65.65
$64.02
$62.35
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
Arrowhead Research Corporation is a publicly-traded nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is building value for shareholders through the progress of majority owned subsidiaries founded on nanotechnologies originally developed at universities. The company works closely with universities to source early stage deals and to generate rights to intellectual property covering promising new nanotechnologies. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications, including anti-cancer drugs, RNAi therapeutics, carbon-based electronics and compound semiconductor materials.
Peers
Alexion Pharmaceuticals
Incyte
Exact Sciences
Charles River Laboratories International
Exelixis
Coherus Biosciences
Luminex
Expectations
›
Arrowhead Pharma